Nektar Therapeutics (BMV:NKTR)

Nektar Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,070	3,575	1,822	8,286	51,115	60,686
Market Cap Growth	-9.01%	96.17%	-78.01%	-83.79%	-15.77%	-15.27%
Enterprise Value	7,434	2,680	-338	3,485	38,260	42,121
Last Close Price	165.00	270.00	766.65	4653.90	4653.90	6186.60
PS Ratio	4.53	1.74	1.20	4.61	24.47	19.94
PB Ratio	28.74	2.82	0.82	1.16	3.67	2.83
P/TBV Ratio	28.74	2.82	0.82	1.46	4.14	3.05
EV/Sales Ratio	4.56	1.31	-	1.94	18.31	13.84
EV/FCF Ratio	-2.04	-	-	-	-	-
Debt / Equity Ratio	13.59	3.20	1.76	0.78	0.50	0.33
Asset Turnover	0.27	0.28	0.16	0.10	0.08	0.09
Inventory Turnover	-	-	1.91	1.24	1.60	1.39
Quick Ratio	3.11	4.18	5.97	7.53	8.90	9.55
Current Ratio	3.24	4.26	6.45	8.01	9.34	9.83
Return on Equity (ROE)	-189.46%	-124.10%	-110.95%	-70.39%	-59.64%	-35.80%
Return on Assets (ROA)	-26.80%	-23.14%	-15.25%	-16.43%	-21.00%	-13.51%
Return on Capital (ROIC)	-31.27%	-26.34%	-16.66%	-17.96%	-22.80%	-14.33%
Earnings Yield	-33.69%	-69.35%	-256.12%	-86.68%	-21.01%	-14.57%
FCF Yield	-45.13%	-103.28%	-179.50%	-72.91%	-17.15%	-10.51%
Buyback Yield / Dilution	-9.53%	-8.24%	-1.53%	-2.10%	-2.64%	-2.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.